Literature DB >> 18954748

Peripheral T-cell non-Hodgkin's lymphoma.

Julie M Vose1.   

Abstract

T-cell non-Hodgkin's lymphoma (T-NHL) are uncommon malignancies accounting for 10% to 15% of all NHL. Geographic variation has been well documented, but the geographic variation may reflect exposure to specific pathogenic viruses, such as Epstein Barr Virus and Human T-cell leukemia virus-1 in Asian countries. The World Health Organization classification specifies 16 major subtypes of T-NHL. Each of the major subtype of peripheral T-NHL has unique characteristics and are addressed separately in this article.

Entities:  

Mesh:

Year:  2008        PMID: 18954748     DOI: 10.1016/j.hoc.2008.07.010

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  15 in total

1.  A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.

Authors:  Yoshihiro Torimoto; Kazuya Sato; Katsuya Ikuta; Toshiaki Hayashi; Yasuo Hirayama; Junki Inamura; Hajime Kobayashi; Ryoji Kobayashi; Kyuhei Koda; Mitsutoshi Kurosawa; Akio Mori; Shuichi Ota; Hajime Sakai; Akio Shigematsu; Motohiro Shindo; Hitoshi Shinzaki; Fumihiko Takahashi; Rishu Takimoto; Junji Tanaka; Satoshi Yamamoto; Yutaka Kohgo; Takashi Fukuhara
Journal:  Int J Hematol       Date:  2013-06-29       Impact factor: 2.490

Review 2.  New targets of therapy in T-cell lymphomas.

Authors:  Jack Erter; Lapo Alinari; Kamruz Darabi; Metin Gurcan; Ramiro Garzon; Guido Marcucci; Mark A Bechtel; Henry Wong; Pierluigi Porcu
Journal:  Curr Drug Targets       Date:  2010-04       Impact factor: 3.465

3.  Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.

Authors:  Rachael Thomas; Eric L Seiser; Alison Motsinger-Reif; Luke Borst; Victor E Valli; Kathryn Kelley; Steven E Suter; David Argyle; Kristine Burgess; Jerold Bell; Kerstin Lindblad-Toh; Jaime F Modiano; Matthew Breen
Journal:  Leuk Lymphoma       Date:  2011-03-07

4.  Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry.

Authors:  Robert N Stuver; Niloufer Khan; Marc Schwartz; Mark Acosta; Massimo Federico; Christian Gisselbrecht; Steven M Horwitz; Frederik Lansigan; Lauren C Pinter-Brown; Barbara Pro; Andrei R Shustov; Francine M Foss; Salvia Jain
Journal:  Am J Hematol       Date:  2019-04-09       Impact factor: 10.047

5.  The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.

Authors:  Steven I Park; Steven M Horwitz; Francine M Foss; Lauren C Pinter-Brown; Kenneth R Carson; Steven T Rosen; Barbara Pro; Eric D Hsi; Massimo Federico; Christian Gisselbrecht; Marc Schwartz; Lisa A Bellm; Mark Acosta; Ranjana H Advani; Tatyana Feldman; Mary Jo Lechowicz; Sonali M Smith; Frederick Lansigan; Anil Tulpule; Michael D Craig; John P Greer; Brad S Kahl; Joseph W Leach; Neil Morganstein; Carla Casulo; Andrei R Shustov
Journal:  Cancer       Date:  2019-01-29       Impact factor: 6.860

6.  Keratitis-Ichthyosis-Deafness Syndrome, Atypical Connexin GJB2 Gene Mutation, and Peripheral T-Cell Lymphoma: More Than a Random Association?

Authors:  Claudio Fozza; Fausto Poddie; Salvatore Contini; Antonio Galleu; Francesca Cottoni; Maurizio Longinotti; Francesco Cucca
Journal:  Case Rep Hematol       Date:  2011-08-10

Review 7.  T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes.

Authors:  Hye Sun Park; Lacey McIntosh; Marta Braschi-Amirfarzan; Atul B Shinagare; Katherine M Krajewski
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

8.  GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3.

Authors:  Lingyun Geng; Kang Lu; Peipei Li; Xinyu Li; Xiangxiang Zhou; Ying Li; Xin Wang
Journal:  Oncotarget       Date:  2017-07-25

9.  T-cell lymphomas in South america and europe.

Authors:  Monica Bellei; Carlos Sergio Chiattone; Stefano Luminari; Emanuela Anna Pesce; Maria Elena Cabrera; Carmino Antonio de Souza; Raul Gabús; Lucia Zoppegno; Lucia Zoppegno; Jorge Milone; Astrid Pavlovsky; Joseph Michael Connors; Francine Mary Foss; Steven Michael Horwitz; Raymond Liang; Silvia Montoto; Stefano Aldo Pileri; Aaron Polliack; Julie Marie Vose; Pier Luigi Zinzani; Emanuele Zucca; Massimo Federico
Journal:  Rev Bras Hematol Hemoter       Date:  2012

10.  13-methyltetradecanoic acid exhibits anti-tumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3.

Authors:  Qingqing Cai; Huiqiang Huang; Dong Qian; Kailin Chen; Junhua Luo; Ying Tian; Tianxin Lin; Tongyu Lin
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.